HLA-B35 is associated with accelerated progression to AIDS

Area of Science:

• Immunogenetics
• Virology
• Epidemiology

Background:

• Human Leukocyte Antigen (HLA) genes play a crucial role in immune response.
• Specific HLA types have been associated with varying rates of infectious disease progression.
• Understanding HLA influences on HIV/AIDS is vital for predicting disease trajectory.

Purpose of the Study:

• To investigate the impact of specific HLA types on the progression and outcomes of human immunodeficiency virus (HIV) infection.
• To determine if HLA specificities influence the rate of Acquired Immunodeficiency Syndrome (AIDS) development.

Main Methods:

• Case-control study of HIV-seropositive individuals (1989-1990) stratified by risk behavior and ethnicity.
• Longitudinal cohort study of HIV-infected male homosexuals (1981-1982).
• Analysis of individuals with diffuse infiltrative CD8 lymphocytosis syndrome.

Main Results:

• HLA-B35 was more frequent in intravenous drug users who developed AIDS compared to asymptomatic controls.
• HLA-B35-positive homosexual men showed a faster progression to AIDS and reduced survival over 7 years.
• HLA-B35 was less frequent in patients with diffuse infiltrative CD8 lymphocytosis syndrome, who had a slower progression to opportunistic infections.

Conclusions:

• HLA-B35 is a significant risk factor for accelerated HIV progression, particularly for opportunistic infections and Kaposi's sarcoma.
• The influence of HLA-B35 on AIDS progression is evident in populations with high rates of new HIV infections.
• Findings suggest a dissociation between HLA-B35 presence and certain AIDS-defining conditions, like lymphoma in specific patient groups.